Agathokleous E, Calabrese EJ (2024) Evolution of hormesis research: a bibliometric analysis. Arch Toxicol 98:577–578. https://doi.org/10.1007/s00204-023-03635-9
Article CAS PubMed Google Scholar
Aria M, Cuccurullo C (2017) bibliometrix: An R-tool for comprehensive science mapping analysis. J Inf 11:959–975. https://doi.org/10.1016/j.joi.2017.08.007
Arruda H, Silva ER, Lessa M, Proenca D Jr, Bartholo R (2022) VOSviewer and Bibliometrix. J Med Libr Assoc 110:392–395. https://doi.org/10.5195/jmla.2022.1434
Article PubMed PubMed Central Google Scholar
Beaufils P (2019) Bibliometrics. Why talk about that? Orthopaed Traumatol Surge Res 105:1423–1424. https://doi.org/10.1016/j.otsr.2019.10.001
Cai X, Wang Z, Li X, Zhang J, Ren Z, Shao Y, Xu Y, Zhu Y (2023) Emodin as an Inhibitor of PRV Infection In Vitro and In Vivo. Molecules 28:6567. https://doi.org/10.3390/molecules28186567
Article CAS PubMed PubMed Central Google Scholar
Cao Y, Chang S, Dong J, Zhu S, Zheng X, Li J, Long R, Zhou Y, Cui J, Zhang Y (2016) Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle. Eur J Pharmacol 780:194–201. https://doi.org/10.1016/j.ejphar.2016.03.049
Article CAS PubMed Google Scholar
Chen P, Huang NY, Pang B, Ye ZJ, Luo RX, Liu C, Gong Q, Wang C, Wang L (2023) Proteomic and metabolomic approaches elucidate the molecular mechanism of emodin against neuropathic pain through modulating the gamma-aminobutyric acid (GABA)-ergic pathway and PI3K/AKT/NF-kappaB pathway. Phytother Res 37:1883–1899. https://doi.org/10.1002/ptr.7704
Article CAS PubMed Google Scholar
Cheng DW, Xu Y, Chen T, Zhen SQ, Meng W, Zhu HL, Liu L, Xie M, Zhen F (2024) Emodin inhibits HDAC6 mediated NLRP3 signaling and relieves chronic inflammatory pain in mice. Exp Ther Med 27:44. https://doi.org/10.3892/etm.2023.12332
Article CAS PubMed Google Scholar
Cui Y-R, Bu Z-Q, Yu H-Y, Yan L-L, Feng J (2023) Emodin attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis. Neural Regen Res 18:1535–1541
Article CAS PubMed Google Scholar
Dong X, Fu J, Yin X, Cao S, Li X, Lin L, Huyiligeqi NJ (2016) Emodin: A review of its pharmacology, toxicity and pharmacokinetics. Phytother Res 30:1207–1218. https://doi.org/10.1002/ptr.5631
Article CAS PubMed PubMed Central Google Scholar
Dong X, Ni B, Fu J, Yin X, You L, Leng X, Liang X, Ni J (2018) Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase-dependent pathway. Oncol Rep 40:1985–1993. https://doi.org/10.3892/or.2018.6620
Article CAS PubMed PubMed Central Google Scholar
Dong X, Zeng Y, Liu Y, You L, Yin X, Fu J, Ni J (2020) Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics. Phytother Res 34:270–281. https://doi.org/10.1002/ptr.6532
Article CAS PubMed Google Scholar
Fu S, Zhou Y, Hu C, Xu Z, Hou J (2022) Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy. BMC Compl Med Ther 22:210. https://doi.org/10.1186/s12906-022-03662-6
Gao J, Zhang K, Wang Y, Guo R, Liu H, Jia C, Sun X, Wu C, Wang W, Du J, Chen J (2020) A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling. Pharmacol Res 155:104739. https://doi.org/10.1016/j.phrs.2020.104739
Article CAS PubMed Google Scholar
Gholampour B, Gholampour S, Noruzi A (2022) Research trend analysis of information science in France based on total, cited and uncited publications: A scientometric and altmetric analysis. Informology 1:7–26
Gholampour S, Gholampour B, Elahi A, Noruzi A, Saboury AA, Hassan SU, Ahmed F, Nawaz R, Terason S (2023) From mega-events hosting to scientific leadership: A seven-decade scientometric analysis of pioneer countries. Cogent Soc Sci 9:2210398
Gholampour B, Noruzi A, Elahi A, Barranco Gil D, Gholampour S (2024) Who are the key figures in Grand Tours cycling events publications? Global Knowledge, Memory and Communication, A systematic review of main themes. https://doi.org/10.1108/gkmc-12-2023-0472
Guo R, Liu N, Liu H, Zhang J, Zhang H, Wang Y, Baruscotti M, Zhao L, Wang Y (2020) High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3. Phytomedicine 68:153171. https://doi.org/10.1016/j.phymed.2020.153171
Article CAS PubMed Google Scholar
Guo Y, Zhang R, Li W (2022) Emodin in cardiovascular disease: The role and therapeutic potential. Front Pharmacol 13:1070567. https://doi.org/10.3389/fphar.2022.1070567
Article CAS PubMed PubMed Central Google Scholar
Han J, Zhang Y, Ge P, Dakal TC, Wen H, Tang S, Luo Y, Yang Q, Hua B, Zhang G, Chen H, Xu C (2023) Exosome-derived CIRP: An amplifier of inflammatory diseases. Front Immunol 14:1066721. https://doi.org/10.3389/fimmu.2023.1066721
Article CAS PubMed PubMed Central Google Scholar
Hassan W, Duarte AE (2024) Bibliometric analysis: A few suggestions. Curr Prob Cardiol 49:102640. https://doi.org/10.1016/j.cpcardiol.2024.102640
Hsu CM, Yen CH, Wang SC, Liu YC, Huang CT, Wang MH, Chuang TM, Ke YL, Yeh TJ, Gau YC, Du JS, Wang HC, Cho SF, Tsai Y, Hsiao CE, Hsiao SY, Hsiao HH (2022) Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy. Biomedicines 10:1638. https://doi.org/10.3390/biomedicines10071638
Article CAS PubMed PubMed Central Google Scholar
Hu N, Liu J, Xue X, Li Y (2020) The effect of emodin on liver disease – comprehensive advances in molecular mechanisms. Eur J Pharmacol 882:173269. https://doi.org/10.1016/j.ejphar.2020.173269
Article CAS PubMed Google Scholar
Hu Y, Yang L, Lai Y (2023) Recent findings regarding the synergistic effects of emodin and its analogs with other bioactive compounds: Insights into new mechanisms. Biomed Pharmacother 162:114585. https://doi.org/10.1016/j.biopha.2023.114585
Article CAS PubMed Google Scholar
Huang Q, Lu G, Shen HM, Chung MC, Ong CN (2007) Anti-cancer properties of anthraquinones from rhubarb. Med Res Rev 27:609–630. https://doi.org/10.1002/med.20094
Article CAS PubMed Google Scholar
Huang W, Wang H, Shen Z, Wang X, Yu X (2024) Association between TyG index and risk of carotid atherosclerosis in NAFLD patients: a retrospective cohort study. Front Endocrinol 15:1448359. https://doi.org/10.3389/fendo.2024.1448359
Hui P, Zhou S, Cao C, Zhao W, Zeng L, Rong X (2023) The elucidation of the anti-inflammatory mechanism of EMO in rheumatoid arthritis through an integrative approach combining bioinformatics and experimental verification. Front Pharmacol 14:1195567. https://doi.org/10.3389/fphar.2023.1195567
Article CAS PubMed PubMed Central Google Scholar
Ioannidis JPA, Maniadis Z (2024) Quantitative research assessment: using metrics against gamed metrics. Intern Emerg Med 19:39–47. https://doi.org/10.1007/s11739-023-03447-w
Jin YZ, Sun HN, Liu Y, Lee DH, Kim JS, Kim SU, Jiao BY, Han YH, Jin MH, Shen GN, Lee DS, Kwon T, Xu DY, Jin YU (2019) Peroxiredoxin V inhibits emodin-induced gastric cancer cell apoptosis via the ROS/Bcl2 pathway. In Vivo 33:1183–1192. https://doi.org/10.21873/invivo.11589
Article CAS PubMed PubMed Central Google Scholar
Kim HJ, Choi JW, Ree J, Lim JS, Lee J, Kim JI, Thapa SB, Sohng JK, Park YI (2022) Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-s
留言 (0)